Showing results (291-300 of 303) with videos related to
Sort By:
Pageof 31
Scientific Data|July 2, 2025
Characterizing organisms from three domains of life with universal primers from throughout the global oceanJesse McNichol, Nathan L R Williams, Yubin Raut, et al.British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.Open Forum Infectious Diseases|March 4, 2024
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022Reagan K Barfield, Matthew L Brown, Benjamin Albrecht, et al.Blood Advances|May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular featuresRivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.Nature Neuroscience|November 24, 2022
Multiregion transcriptomic profiling of the primate brain reveals signatures of aging and the social environmentKenneth L Chiou, Alex R DeCasien, Katherina P Rees, et al.Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.Pageof 31